A Small-Molecule Inhibitor of Prion Replication and Mutant Prion Protein Toxicity
作者:Tania Massignan、Valeria Sangiovanni、Silvia Biggi、Claudia Stincardini、Saioa R. Elezgarai、Giulia Maietta、Ivan A. Andreev、Nina K. Ratmanova、Dmitry S. Belov、Evgeny R. Lukyanenko、Grigory M. Belov、Maria Letizia Barreca、Andrea Altieri、Alexander V. Kurkin、Emiliano Biasini
DOI:10.1002/cmdc.201700302
日期:2017.8.22
Into the fold: Prion diseases are neurodegenerative disorders characterized by the accumulation in the brain of a self-replicating, misfolded isoform (PrPSc ) of the cellular prion protein (PrPC ). No therapies are available for these pathologies. We capitalized on previously described cell-based assays to screen a library of small molecules, and identified 55, a compound capable of counteracting both
折叠:Pri病毒疾病是神经退行性疾病,其特征是细胞病毒蛋白(PrPC)的自我复制,错误折叠的同工型(PrPSc)在大脑中积累。没有针对这些病理的疗法。我们利用先前描述的基于细胞的分析方法来筛选小分子文库,并鉴定出55种能够抵消病毒复制和毒性的化合物。化合物55可以代表开发病毒疾病的全新疗法的起点。